Bio-Com International

Description

• Bio-Com International, a biotech commercial-development consultancy, provides expert advisory services for translating emerging innovative advancements from the bench to the marketplace. To build & sustain its clients' competitive advantage, Bio-Com assists with risk/reward assessment & decision making. The firm also evaluates the economic impact of proprietary technologies for all phases of the intellectual property life cycle. Programs entail: Conduct strategic business roadmapping: tech/market gap analysis of new opps Deploy rigorous financial analyses driving value-based negotiations & decisions Optimize R&D / product dev. resource allocation by analyzing capital budgeting / investments as Real Options Build winning product & corp. strategies by employing discovery-driven planning & customer development Provide forward-thinking market info, research & business intelligence Assess & mitigate potential patent infringement, transactional & operational risksBio-Com offers formidable financial & commercial capabilities plus technical/IP expertise. A key differentiator stems from its cross-functional BIOSCIENCE-IP-BUSINESS experience. NPV-driven quantitative tools are central to the firm's sweet spot: decision-analysis & strategy-development. Projects include evaluating the commercial potential of: Molecular diagnostics (mDx) & next generation sequencing (NGS) platforms Genomics-guided drug discovery & development tools CDx-stratified targeted therapeutics aka personalized / precision medicine
• 

  Headquarters:450 E Waterside Dr Unit 210 , Chicago, Illinois, United States

  More
• 

  Phone Number:

• 

  Website:

• 

  Employees:0

• 

  Revenue:$0 - 1M

• 

  Legal Name:Bio-Com International

• Bio-Com International's Social Media

  
• Is this data correct?

• |  NAICS Code: 541320  |

  Show More